fda glp-1 safety alert october 2025 Trends In FY Warning Letters FDA Finds No Increased Suicide

Men with pre-existing symptoms suggestive of hypogonadismincluding persistent fatigue, reduced libido, erectile dysfunction, decreased muscle mass, or depressed moodshould undergo testosterone evaluation before initiating semaglutide

Although GLP-1RAs attenuate inflammatory signaling [105], NAD metabolism remains dynamically regulated and tissue-specific [83, 106, 109]

4.2.0) and, for multiply imputed datasets, MatchThem (v

This is because, in about 4.0% to 6.5% of cases, these nodules can represent thyroid cancer

In a 10-2 vote Thursday, the Oncologic Drugs Advisory Committee determined that progression-free survival (PFS) data from the Phase III confirmatory CodeBreaK 200 study could not be reliably interpreted